StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
InvestmentJul 2, 2026, 05:17 PM

Avalon GloboCare Raises $400K via Series F Preferred Stock Sale

AI Summary

Avalon GloboCare Corp. entered into a securities purchase agreement to sell 400 shares of Series F Convertible Preferred Stock and 200,000 shares of common stock to an accredited investor for an aggregate purchase price of $400,000. The Series F Preferred Stock is convertible at $0.50 per share and is subject to mandatory redemption at 125% of its stated value. Additionally, the company issued various restricted common shares and stock options to consultants, officers, and non-employee directors for services rendered and as compensation.

Key Highlights

  • Sold 400 Series F Preferred Stock and 200,000 common shares for $400,000.
  • Series F Preferred Stock convertible into common stock at $0.50 per share.
  • Series F Preferred Stock subject to mandatory redemption at 125% of stated value.
  • Issued 150,000 restricted common shares to a consultant for services rendered.
  • Issued options to purchase 400,000 common shares to consultants.
  • Issued 750,000 restricted common shares to consultants for services rendered.
  • Issued options to purchase 1,150,000 common shares to officers.
  • Issued options to purchase 600,000 common shares to non-employee directors.